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1. Introduction 
Asymmetric division is a process by which stem cells asymmetrically segregate certain 
proteins, called “cell fate determinants”, in order to generate two functionally different cells.  
Normally, one of the daughter cells terminally differentiates while the other retains stem cell 
properties and continues proliferating.  Asymmetric division has been found in virtually all 
developing systems where stem cells need to simultaneously proliferate and generate 
differentiated cells: brain, skin, gut, mammary gland, hematopoiesis, also in plants and 
algae. As a consequence of these studies, it has been established that, by virtue of 
asymmetric division, both developing and adult organs maintain the delicate equilibrium 
between proliferation and differentiation. The recent discovery of links to cancer has added 
momentum to an already very dynamic research area.  This review article will discuss the 
latest developments in the asymmetric division field, with a focus on the immuno-
hematopoietic system.  
2. Historical perspective 
The hypothesis about the existence of asymmetric division was postulated in 1878 based on 
studies of leech development, where certain cytoplasmic domains of the egg are 
differentially segregated to the descendants (Whitman, 1878).   In the 1980s asymmetric 
division was described and analyzed in many other organisms, like yeasts, nematode, algae 
and Drosophila (see Horvitz and Herskowitz 1992 for a comprehensive review). At this stage, 
it was thought that each organism had a different means to undergo asymmetric division. 
Daughter cells acquired the differences that made them differentiate into various lineages 
either intrinsically (by differential inheritance of cytoplasmic or chromosomal factors) or 
extrinsically, by differential segregation of soluble factors. Intrinsic differences were 
described in expression of transcription factors, chromatin components, nucleases, 
receptors, cytoskeletal proteins and others; however, at this point it was not clear which of 
them were involved in generating asymmetry or were subject to asymmetric segregation 
themselves to influence differentiation. Extrinsic asymmetric cell division seemed to be the 
result of either direct cell-cell contact, or secretion of soluble factors. We will focus on 
intrinsic asymmetric division, which has been most widely studied. 
In the 1990s, Drosophila asymmetric division was analyzed in detail and visualized by 
confocal microscopy (Rhyu, Jan, and Jan 1994). Two proteins with antagonistic function, 
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Numb and Notch, were pointed out as the main characters in this complicated process.  This 
was followed by the description of asymmetric division in mammalian brain, with a similar 
mechanism and also involving asymmetric segregation of Numb (Zhong et al. 1996). At this 
point, Numb function was unknown, however it was discovered that it could bind (and 
antagonize) the transmembrane receptor Notch. During the following years, efforts in the 
two main invertebrate model systems, C. elegans and Drosophila, were focused on the 
mechanisms to set up cell polarity previous to division, spindle positioning and asymmetric 
localization of cell fate determinants (Betschinger and Knoblich 2004). Studies on vertebrates 
showed that many of the proteins involved were conserved, and that there may be a general 
mechanism for asymmetric division, conserved from the most ancient organisms up to our 
own brain and muscles. These discoveries resulted on a shift of research in the direction of 
vertebrates and, concretely, mammalians, and soon asymmetric division was first described 
in the hematopoietic system (Wu et al. 2007; Schroeder 2007). Studies in Drosophila were still 
ahead, thus the first link between cancer and asymmetric division was discovered in 
Drosophila earlier than in mammalians (Caussinus and Gonzalez 2005). In the following 
years, an important role for phosphorylation of cell fate determinants during mitosis was 
described (Wirtz-Peitz, Nishimura, and Knoblich 2008). Additionally, the mechanisms for 
asymmetric inheritance of centrioles (mediated by microtubules), DNA and vesicles were 
discovered [reviewed in (Neumuller and Knoblich 2009)].   It was realized that, although the 
proteins involved in asymmetric division are conserved, their roles are different in 
vertebrates. However, Drosophila studies were vey helpful in the case of the link to cancer, 
and a molecular mechanism involving Numb and p53 was discovered (Colaluca et al. 2008). 
The challenge for the next decade will be to integrate all this knowledge at the systems level 
to understand how asymmetric division works in health and disease, with enormous 
implications for stem cell research.  
3. Molecular mechanisms of asymmetric division 
Although the mechanism of asymmetric cell division has been intensively studied, there is 
no general model of how it occurs, because the data have been obtained studying different 
organisms that normally have their own specificity. Besides, different techniques, 
depending on the field, have been used to obtain the data, making it difficult to discern real 
differences from those arising as a result of using different techniques. Another problem, 
even when dealing with a single model system, is that there are data on asymmetric 
segregation of different proteins and organelles of the cell, but these data are not connected 
either temporally or mechanistically.  A considerable effort to unify this knowledge into a 
common model has been made by J. Knoblich, who has continually summarized the data 
from diverse model systems in a series of excellent reviews  [specifically (Knoblich 2010) 
(Neumuller and Knoblich 2009) are of great help in understanding the underlying 
mechanisms of asymmetric division]. We will first summarize the current knowledge on 
how different components of the cell are asymmetrically segregated.  
Membrane adaptors- The first stage of asymmetric division in Drosophila neuroblasts is 
polarization of the cell fate determinants Numb (an endocytic adaptor) and Miranda (an 
adaptor that recruits other proteins to the membrane), as a result of asymmetric 
phosphorylation by aPKC (Wirtz-Peitz, Nishimura, and Knoblich 2008).  If Numb and 
Miranda are phosphorylated by aPKC, they cannot localize to the membrane and exert their 
function (Wirtz-Peitz, Nishimura, and Knoblich 2008). During interphase, aPKC is bound to 
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PAR6 and Numb to L(2)GL, which allows Numb to be at the membrane. When the cell 
enters mitosis, Aurora A phosphorylates PAR6, resulting in L(2)GL phosphorylation and 
decoupling from Numb, allowing the adaptor PAR3 to bind simultaneously to both Numb 
and aPKC. Numb is then phosphorylated by aPKC and excluded from the membrane as a 
consequence (Smith et al. 2007; Wirtz-Peitz, Nishimura, and Knoblich 2008). Since aPKC is 
asymmetrically positioned in a constitutive fashion, this automatically results in asymmetric 
membrane distribution of Numb. This mechanism seems to be conserved in mammalians. 
Vesicular compartments- Both endocytic adaptors (like Numb) and vesicles have been 
described to segregate asymmetrically both in Drosophila and mammalians (Zhong et al. 
1996; Le Borgne and Schweisguth 2003). Most transmembrane receptors are subject to 
constant internalization, degradation and recycling, and the balance between these defines 
signaling levels at each moment. It is also known that receptors inside the endosomes do not 
only undergo degradation, but are also able to signal, sometimes even at a stronger level 
than on the membrane (Miaczynska and Bar-Sagi, 2010). This indicates that asymmetric 
segregation of vesicular compartments is a means to enhance signaling by certain receptors 
in one of the daughter cells at the expense of the other. Interestingly, such asymmetric 
segregation of vesicles or proteins involved in endocytosis has been shown to exist in the 
hematopoietic system (Aguado et al. 2010; Giebel and Beckmann 2007). 
Microtubules- During telophase, microtubules play a role in spindle orientation and 
maintenance of Numb and Miranda asymmetric segregation, although the mechanism is not 
completely understood (Knoblich 2010).  
Centrioles- It has been shown that centrioles are asymmetrically segregated in neuroblasts 
(the old centriole normally remains with the cell retaining progenitor potential) and this 
may play a role in cell fate determination (Yamashita et al. 2007). 
DNA- There is evidence in some model systems of asymmetric DNA segregation, where the 
“template” DNA strand is retained by the less differentiated cell. This seems to be true for 
intestinal epithelium (Potten et al. 1978), muscle (Shinin et al. 2006), and neural stem cells 
(Karpowicz et al. 2005) but not for hair follicle (Sotiropoulou, Candi, and Blanpain 2008) or 
hematopoietic (Kiel et al. 2007) stem cells. However, it is not clear whether these disparities 
arise from looking at cells with different specifics in terms of lag between divisions.  
Ribosomal components- In Drosophila, the cell that retains stem cell properties has been shown 
to present both increased size and enhanced protein synthesis. This seems to be related to 
asymmetric segregation of ribosomes (Neumuller et al. 2008) and other factors involved in 
protein synthesis (Fichelson et al. 2009). This has not yet been demonstrated in 
mammalians, but nevertheless is very intriguing and may be the mechanism by which the 
capacity to keep proliferating is asymmetrically inherited by just one of the precursors 
during development.  
At this point, the data indicate that the main mechanism of asymmetric division consists on 
asymmetric inheritance of diverse proteins and subcellular structures, which in its turn 
helps to enhance the difference between the two daughter cells, so that one can retain stem 
cell capabilities while the other terminally differentiates. In this way, asymmetric 
segregation of endocytic adaptors, vesicles and microtubules may contribute to differential 
signaling in the two daughter cells, while differential inheritance of centrioles, DNA and 
ribosomes may help preserve stem cell capabilities in just one of the cells.  
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Two other important aspects that influence asymmetric division are polarization and 
spindle orientation during cell division. Polarization has been most extensively studied in 
C. elegans, where a complex formed by the proteins Par-3, Par-6 and aPKC are already 
polarized during interphase (Suzuki and Ohno 2006).  This mechanism is conserved in 
Drosophila and is involved in all processes that depend on cell polarity. The mentioned 
complex is located in the apical part of the cell and, in mammalian cells, is combined with 
Cadherin and mediates adhesion. Thus, when the spindle forms during cell division, its 
orientation is crucial to determine symmetry or asymmetry. If the spindle is positioned 
perpendicular to the Par complex, the cell divides asymmetrically, and the daughter cell that 
inherits the complex remains a stem cell (probably through adhesion to the stem cell niche), 
while the other daughter cell abandons the cell niche and differentiates. On the contrary, if 
the spindle axis parts the Par complex, both daughter cells inherit it and the division is 
symmetric (Knoblich 2010; Fig. 1). 
 
Fig. 1. Polarization and spindle orientation during symmetric or asymmetric division in  
C. elelgans. 
Undoubtedly, in the future all these facts will be unified in a single model explaining how 
and when things happen during asymmetric division, independently of individual 
differences among the various model systems used to obtain the data. 
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4. Asymmetric division during normal hematopoiesis 
Hematopoiesis is the process by which about 7x109  blood cells are replaced everyday and 
per kg to maintain the Hematopoietic Stem Cell (HSC) pool in an organism. On the other 
hand, a HSC can be defined as a clonogenic cell that has the capacity to self-renew and 
differentiate into the progenitors of mature blood cells through a symmetric or an 
asymmetric division, respectively. 
The hematopoietic system in mammalians shows a hierarchical structure. There is a wide 
range of distinct mature cells, such as erythrocytes, megacaryocytes, myeloid cells, mast 
cells, NK cells, monocytes, B and T cells, and others (Figure 2). All these different cells share 
a common progenitor cell, the Hematopoietic Stem Cell (HSC). HSCs can divide trough a 
symmetric process to self-renew or through an asymmetric division process to generate 
daughter cells with different fates: one daughter cell with the same fate as the progenitor 
cell, and the second one with Multipotent Progenitor cell fate (MPP). Later, MPPs go 
downstream through the hierarchy and can divide into three different Oligopotent 
Progeitors (OPPs). These three different OPPs are Common Lymphoid Progenitors (CLPs), 
megakaryocyte/erythrocyte progenitors (MEPs) and Common Myeloid Progenitors (CMPs). 
The last type of OPPs can generate other OPPs such as granulocyte/macrophage 
progenitors (GMPs) or MEPs. Then, these OPPs derive in a wide range of Lineage Restricted 
Progenitors, such as pro-B lymphoid cells, pro-T lymphoid cells, pro-NK cells, etc., to finally 
generate Mature Effector Cells (platelets, dendritic cells, macrophages, erytorocytes, NK, B 
& T cells, etc). It must be emphasized that multipotency is lost during this process, therefore, 
the potency to generate two daughter cells with different fates is reduced from HSCs to 
mature effector cells (Seita and Weissman 2010). 
 
Fig. 2. Schematic representation of precursor decisions during hematopoiesis. 
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In symmetric divisions, identical copies of the progenitor cell are generated, maintaining the 
pool of HSCs. On the other hand, asymmetric divisions contribute to generate diversity. 
Although it is accepted that the capacity to generate cells with different fates is an intrinsic 
property of HSCs, and studies with fluorescent proteins have shown that several 
determinant factors can be asymmetrically distributed during mitosis (Congdon and Reya 
2008), the environment has an important role in asymmetric division, as well. Thus, several 
studies have indicated that the stroma plays an important role in differentiation of HSCs 
into all blood cell types (Purton and Scadden 2008). In this study, different cell lineages with 
various fates were obtained culturing the HSCs in the presence of different stromas. Other 
studies indicate that osteoblasts and endothelial cells act as stem cell niches and may play an 
important role in progenitor diversity generation. Some experiments show that when HSCs 
are cultured in the presence of osteoblasts asymmetric division is induced, and symmetric 
division is more frequent when HSCs are cultured on stromal cells. In addition, experiments 
where HSCs were cultured in presence or not of Lnk, trombopoeitin (TPO) and several 
interleukins such as IL-3, IL-6 and IL-11 showed effects in self-renewal and differentiation 
processes. For instance, Lnk is considered a negative regulator of self-renewal while TPO is 
a negative regulator of differentiation. In addition, there are other cell types with a potential 
role as regulators of the HSC niche. One of them is the sympathetic nervous system 
(Katayama et al. 2006). Therefore, it seems that asymmetric division is an important process 
for hematopoiesis, although the molecular details remain to be elucidated. 
5. Role of cell fate determinants in hematopoietic malignant proliferation 
The plasma membrane receptor Notch in directly implicated in the proliferative/ 
differentiative balance of stem cells. Thus, deregulation in Notch signaling is related with 
several diseases, such as cancer. An increase in Notch signaling results in the development 
of adenocarcinomas in lung and mammary gland (Allen et al. 2010; Farnie and Clarke 2007). 
Notch1 can be found in many hematopoietic tissues, such as peripheral T and B cells, 
neutrophils and bone marrow precursors (Stier et al. 2002), and activation of Notch1 
increases self-renewal of HSCs while inhibiting the generation of mature cells. This supports 
previous in vitro studies where Notch activation produced immortalized clones of 
multipotent cells (Stier et al. 2002; Varnum-Finney et al. 2000), however Notch1 did not 
completely block the generation of mature cells.  
The first proof of the relationship between Notch signaling and cancer was found in acute T 
lymphoblastic leukemia (T-ALL), and afterwards Notch signaling was shown to be involved 
in generation of solid tumors, including melanoma, colorectal cancer, breast cancer, non-
small cell lung carcinoma and others (Ranganathan, P., et al. 2011). Currently, Notch 
signaling is receiving increased attention in the development of new therapies against 
cancer. Some studies have shown that its ligands (specifically Dll4, involved in angiogenesis 
and T cell fate specification) are overexpressed in different kinds of cancer (Stylianou S, et al. 
2006).  As a result, several ways of inhibiting Notch signaling are being tested at different 
levels:  
Synthetic inhibitors. The Notch pathway is inhibited by small compounds, which arrest the 
proteolysis of Notch receptors by the -secretases-presenilin complex or interfere with the 
activity of the Notch intracellular domain.  The most common -secretases (GSIs) are DAPT 
and DBZ (dibenzazepine). In addition, specific inhibitors for Dll4-Notch signaling have been 
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developed as well. Although different versions of these inhibitors can be found, all of them 
present the same disadvantage. Initially, these drugs were developed to arrest proteolysis of 
the amyloid precursor protein (APP) in Alzehimer’s disease and therefore, they are not 
specific and normally interfere with a wide range of different pathways. On the other hand, 
dnMAML1, a dominant negative of Mastermind-like 1 (MAML1) represents a more selective 
option. dnMAML1 blocks the transduction of the four known Notch receptors (Notch 1-4). 
Although dnMAML1 is a potent inhibitor, it shows low levels of cell permeability; for this 
reason, similar compounds with a better cell permeability have been developed. All these 
inhibitors down-regulate Notch signaling and have shown good results in treating T-ALL. 
Endogenous inhibitors. Endogenous inhibitors, such as Fwb (an E3 ligase), Cbl, Numb and 
Numblike can be used to regulate Notch signaling by targeting Notch receptors, however, 
an important disadvantage is their poor specifity. On the other hand, soluble inhibitors such 
as the extracellular domains of Jagged1, DLk1 and EGFL7 can offer a more specific 
alternative. However, it must be considered that the mechanism of these inhibitors is not 
well known and their role in Notch signaling must be studied in detail. 
Antibodies. Antibodies against Notch receptors can be used to regulate Notch signaling. 
Some antibodies have been already developed against Notch1 and Notch3 receptors (Asano 
N., et al. 2008, Elyaman W., et al 2007, Jurynczyk M., et al 2008, Maekawa Y., et al 2003, 
Schaller MA., et al. 2007 and Li K., et al. 2008). Antibodies can block specific Notch receptors 
with a high selectivity, leaving other Notch receptors activated.  For example, an anti-Dll4 
antibody has been developed against Dll4-Notch signaling and it is showing promising 
perspectives in anti-angiogenic cancer therapy because of its low toxicity (Ridgway J, et al. 
2006). A similar strategy uses molecules called decoys. Decoys are soluble extracellular 
domains of Notch receptors or ligands. They compete with Notch receptors, inhibiting 
Notch signaling by binding to endogenous molecules. These associations do not trigger 
Notch signaling because of lacking the transmembrane region. Notch signaling in 
endothelial cells has been inhibited using a decoy of Notch1, successfully reducing tumor 
growth. Other decoys of Dll1, Dll4 and Jagged1 have been successfully developed 
(Funahashi Y., et al. 2008, Varnum-Finney B., et al. 2000 and Small D., et al. 2001). However, 
decoys show an important disadvantage. It has been observed that they can be switched 
from inhibitors into activators easily. The association of decoys with extracellular matrix can 
produce an activator and trigger Notch proteolysis and activation. The process by which a 
decoy can be transformed into an activator is not yet fully understood, and this feature 
makes decoys unpredictable and not valid as therapeutics (Hicks C., et al. 2002). 
Notch is regulated by Numb, and loss of this regulation has been described in more than 
50% of human mammary carcinomas. When Numb is lost, Notch signaling is increased, and 
the balance between self-renewal and differentiation is affected, which results in 
uncontrolled proliferation.  Loss of Numb may be due to ubiquitylation and subsequent 
proteosomal degradation.  
Recent studies carried out by Colaluca et al. (Colaluca et al. 2008) showed that Numb plays 
an important role in the regulation of the protein p53, also called TP53, an important tumor 
suppressor involved in 50% of breast cancers and in 70% of colon cancers. Numb binds to 
p53 and the E3 ubiquitin ligase HDM2 (or MDMD2 ligase) to form a triple complex, 
inhibiting p53 ubiquitylation and, therefore, its degradation. As a consequence, p53 levels 
are higher and the apparition of breast cancer is diminished. When there is loss of Numb, 
www.intechopen.com
 
Hematology – Science and Practice 
 
128 
p53 degradation is higher, allowing higher expression of Notch, which results in 
chemoresistance to the drugs used to combat the disease and in uncontrolled cellular 
proliferation. Besides, p53 regulates the expression of genes implicated in cell-cycle arrest 
and apoptosis upon cellular stress. Additionally, it acts as transcriptional factor. Therefore, it 
seems clear that there is a relationship between Numb deregulation and uncontrolled 
cellular proliferation via the tumor suppressor p53. However, the mechanism by which 
Numb regulates p53 remains still unclear (Carter and Vousden 2008).  
In some cases, such as in breast cancers, deficiency in Numb expression is due to an increase 
in ubiquitylation resulting in higher proteasomal degradation. This may be related to 
increased levels or activity of E3-ligases such as LNK, Siah-1 and MDM2. Another 
explanation for Numb loss may be ubiquitylation after over-phosphorylation. Restoration of 
Numb normal levels could be achieved pharmacologically using substances with 
antiproteasomal activity such as PS-341 or enzymatic inhibitors of Numb degradation (Pece 
et al. 2004). These investigations have a clear practical application: hopefully, in the future 
some of the resulting knowledge will be applied to the clinic. 
6. Asymmetric division in the immune system 
During immune system development and function, progenitor cells undergo a series of 
proliferation and differentiation processes in order to generate the different mature cell 
populations that protect the body from foreign pathogens. T cells develop in the thymus 
from bone marrow precursors through a series of intermediate stages. Double negative cells 
(DN) undergo some division rounds before differentiating into double positive cells (DP), 
afterwards T cell progenitors do not divide again in the thymus: only after exiting the 
thymus and populating the periphery will mature T cells be able to proliferate again. During 
the immune response, naive T lymphocytes (T lymphocytes recently created that have not 
encountered antigen) are activated by antigen-presenting cells.  Naive T cell activation, 
through the T cell receptor (TCR), leads to proliferation and differentiation, triggering a 
massive expansion of differentiated effector cells, as well as a small number of memory cells 
(these will remain undifferentiated until subsequent antigen encounters). Thus, after T cell 
activation, a single naïve T cell is able to generate many different T cell types in order to 
orchestrate an effective immune response (Stemberger et al. 2007). How can a single cell 
generate all the T lymphocyte types that are required for immunity? This question has 
fascinated immunologists over the past years. Several models have been suggested to 
explain the generation of subset diversity during the immune response. Some studies 
suggest a progressive differentiation model (Sallusto, Geginat, and Lanzavecchia 2004), 
while others suggest an early bifurcation between effector and memory phenotypes, more 
consistent with asymmetric division, but the question remains controversial. Despite 
asymmetric division being the most widespread process that regulates the generation of a 
variety of cell types, this process has only started to be studied in the immune system in the 
last few years, and it still remains controversial.  
Nothing suggests, a priori, that the widespread principle of asymmetric division should not 
be applied to the thymus, where DN cell proliferation does regulate the total number of cells 
in the whole organ, and during this process, precursor cells resulting from such divisions 
must decide between differentiation and proliferation. In this respect, three different aspects 
should have been studied before making statements about the role of asymmetrically 
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segregated cell fate determinants in thymocytes. First, demonstration of the existence of 
asymmetric division itself (including an assessment of the effect of manipulating 
asymmetric division); second, identification of cell fate determinants that are asymmetrically 
segregated and their signaling pathways; finally, elucidation of the mechanisms that lead to 
asymmetric localization of these determinants, including external cues that regulate cell 
polarization, as well as intracellular processes that mediate asymmetric segregation of 
proteins and organelles (as has been described before for studies of both Drosophila and 
mammalian neural system).  
However, the first studies related to asymmetric division in the thymus used either 
transgenic or knockout mice to over-express or delete Numb (French et al. 2002; Anderson et 
al. 2005; Wilson et al. 2007).  In these studies, investigators used classical assessments of 
thymocyte differentiation in order to determine whether or not Numb played a role in 
thymocyte differentiation (they never examined asymmetric division). The conclusion 
drawn by the three studies was that Numb plays no role in thymus differentiation. 
However, there are three important considerations that were not taken into account. First, 
both Numb and its homologue Numblike are expressed in mammalians (the thymus 
included), and if their levels are reduced so that just 1% of endogenous levels of either 
Numb or Numblike remain in the cells, this is still enough to maintain normal asymmetric 
division (Petersen et al. 2002; Petersen et al. 2006). Second, four different isoforms of Numb 
are expressed in mammalians (Dho et al. 1999). Third, knockout studies in the immune 
system must be taken with caution, since there is accumulating evidence that the absence of 
phenotype does not necessarily mean that the protein does not have a function (Saveliev 
and Tybulewicz 2009). If Numb acts as a cell fate determinant during asymmetric division in 
the thymus, one would expect an effect in precursor proliferation rate and the total number 
of thymocytes, however none of these were examined in these first studies. Nevertheless, 
the existence of three studies claiming no role for Numb in the thymus predisposed the 
whole field against the notion of asymmetric division.  
Fortunately, over the past few years, the first studies on asymmetric division in the thymus 
and peripheral T lymphocytes performed following a more logical order (i.e., examining in 
the first place asymmetric segregation of determinants) have provided exciting data about 
asymmetric division in the immune system (Aguado et al. 2010; Chang et al. 2007).  In the 
first study, our group showed by confocal microscopy that Numb is segregated 
asymmetrically during thymocyte division. By inhibiting Numb (using a dominant 
negative), or overexpressing it, we showed that functional Numb levels determine DN 
thymocyte proliferation rate and, ultimately, thymus size. Furthermore, we showed that 
Numb can regulate pre-TCR localization and signaling, acting as an endocytic protein. As a 
result, a model was proposed where thymocytes divide by asymmetric division to generate 
one daughter cell that inherits Numb and keeps precursor properties and a second that does 
not inherit Numb and receives pre-TCR signaling as a consequence, which results in 
differentiation (Fig. 3). The second study showed that peripheral CD8+ T cells do indeed 
undergo asymmetric division, and this process regulates the choice between effector and 
memory differentiation (Chang et al. 2007). The authors showed that after the first naïve 
CD8+ T cell division, the proximal and distal daughter cells have different phenotypes. Thus, 
proximal daughter cells expressed low CD62L levels and higher CD69, CD43 and CD25 
levels. Furthermore, when these cells were transferred into naïve secondary recipients, they 
provided protection against acute infection, but poor long-term protection, a profile 
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consistent with the effector lineage. However, distal daughters expressed high levels of 
CD62L and lower levels of CD69, CD43, CD25 and CD44 and these cells provided a good 
long-term protection in vivo, a profile more consistent with the central memory cells. This is 
clear evidence that asymmetric division occurs, at least during the first division.  
As we have explained before, for asymmetric division to occur, the progenitor cell needs to 
receive an external cue to dictate the axis of polarity, recruit cell fate determinants and align 
the mitotic spindle with a correct position that ensures asymmetric segregation of the 
determinants. During mature T cell division, the axis of polarity and mitotic spindle 
alignment are established by the formation of the immunological synapse. The 
immunological synapse has been extensively studied as a site of clustered signaling 
molecules, and can be considered as a marker of the polarized T cell and a mechanism for 
asymmetric division regulation. Recent studies showed that asymmetric cell division is not 
observed either during non antigen–dependent activation or the second and subsequent cell 
divisions following antigen stimulation, and that the polarity cue for asymmetric cell 
division requires the contact with antigen-presenting cells (Chang et al. 2007; Oliaro et al. 
2010; Fig. 3). One problem with this model is that if it is just the first division that is  
 
Fig. 3. Schematic representation of the current models for asymmetric division in thymus 
and periphery. 
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asymmetric during the immune response, and all the subsequent divisions are symmetric, it 
is not clear how the final numbers of memory and effector cells are achieved. In any case, 
these data on thymus and peripheral T cells demonstrate that the immunological system is 
not a remarkable exception to the principle of asymmetric division as the universal 
mechanism to ensure a correct balance between expansion and differentiation during 
development. The mechanistic details on how asymmetric division is orchestrated in the 
immune system in order to achieve correct numbers of mature cells will surely be elucidated 
soon. 
7. Future directions of the field 
Asymmetric division has transitioned from being an intriguing but unexplained anomaly of 
neural development into a fertile field where scientists working on different developmental 
biology areas converge to exchange methods and ideas. The recently discovered link to 
cancer stresses out the importance of these studies in the immuno-hematopoietic system.  
An important current challenge for the field of asymmetric division is unification of 
knowledge. A general model for the functioning of asymmetric division that applies to all 
organisms and tissues needs to be postulated, even if it is very schematic at the beginning. 
Next, unification of methods should be achieved: the same phenomenon in different 
organisms should not be studied using different techniques simply because researchers of 
different areas feel more comfortable with a certain approach. To avoid this, more joint 
scientific meetings on asymmetric division must be organized, so that researchers can 
exchange views and knowledge, besides funding should be available for those willing to 
assume the risk of applying new techniques to old model systems.  If the field does not 
evolve in this way, it risks loosing its current novelty and drive.  Hopefully, new exciting 
discoveries will keep the area alive, and the many open questions about how organisms and 
tissues orchestrate growth and differentiation will be answered soon.  
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